Activation of toll-like receptors 2 and 4 on CD34+ cells increases human megakaryo/thrombopoiesis induced by thrombopoietin

J Thromb Haemost. 2019 Dec;17(12):2196-2210. doi: 10.1111/jth.14605. Epub 2019 Sep 13.

Abstract

Background: Platelet Toll-like receptor (TLR)2/4 are key players in amplifying the host immune response; however, their role in human megakaryo/thrombopoiesis has not yet been defined.

Objectives: We evaluated whether Pam3CSK4 or lipopolysaccharide (LPS), TLR2/4 ligands respectively, modulate human megakaryocyte development and platelet production.

Methods: CD34+ cells from human umbilical cord were stimulated with LPS or Pam3CSK4 with or without thrombopoietin (TPO).

Results: CD34+ cells and megakaryocytes express TLR2 and TLR4 at both RNA and protein level; however, direct stimulation of CD34+ cells with LPS or Pam3CSK4 had no effect on cell growth. Interestingly, both TLR ligands markedly increased TPO-induced CD34+ cell proliferation, megakaryocyte number and maturity, proplatelet and platelet production when added at day 0. In contrast, this synergism was not observed when TLR agonists were added 7 days after TPO addition. Interleukin-6 (IL-6) release was observed upon CD34+ or megakaryocyte stimulation with LPS or Pam3CSK4 but not with TPO and this effect was potentiated in combination with TPO. The increased proliferation and IL-6 production induced by TPO + LPS or Pam3CSK4 were suppressed by TLR2/4 or IL-6 neutralizing antibodies, as well as by PI3K/AKT and nuclear factor-κB inhibitors. Additionally, increased proplatelet and platelet production were associated with enhanced nuclear translocation of nuclear factor-E2. Finally, the supernatants of CD34+ cells stimulated with TPO+LPS-induced CFU-M colonies.

Conclusions: Our data suggest that the activation of TLR2 and TLR4 in CD34+ cells and megakaryocytes in the presence of TPO may contribute to warrant platelet provision during infection episodes by an autocrine IL-6 loop triggered by PI3K/NF-κB axes.

Keywords: NF-kappa B; interleukin-6; megakaryocytes; platelets; toll-like receptor 2/4.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD34 / metabolism*
  • Blood Platelets / drug effects*
  • Blood Platelets / immunology
  • Blood Platelets / metabolism
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Humans
  • Interleukin-6 / metabolism
  • Lipopeptides / pharmacology*
  • Lipopolysaccharides / pharmacology*
  • Megakaryocytes / drug effects*
  • Megakaryocytes / immunology
  • Megakaryocytes / metabolism
  • NF-kappa B / metabolism
  • Phosphatidylinositol 3-Kinase / metabolism
  • Signal Transduction
  • Thrombopoiesis / drug effects*
  • Thrombopoietin / pharmacology*
  • Toll-Like Receptor 2 / agonists*
  • Toll-Like Receptor 2 / genetics
  • Toll-Like Receptor 2 / metabolism
  • Toll-Like Receptor 4 / agonists*
  • Toll-Like Receptor 4 / genetics
  • Toll-Like Receptor 4 / metabolism

Substances

  • Antigens, CD34
  • IL6 protein, human
  • Interleukin-6
  • Lipopeptides
  • Lipopolysaccharides
  • NF-kappa B
  • Pam(3)CSK(4) peptide
  • TLR2 protein, human
  • TLR4 protein, human
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4
  • lipopolysaccharide, Escherichia coli O111 B4
  • Thrombopoietin
  • Phosphatidylinositol 3-Kinase